Home
News
Create
Screeners
Insights
Innova Captab
767.
50
-35.45
(-4.41%)
Market Cap
₹4,392.00 Cr
PE Ratio
33.85
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-4.41%
1M
-8.11%
6M
-12.37%
1Y
-10.99%
5Y
+41.76%
View Company Insights
Latest news about Innova Captab
Innova Captab Targets 25% Revenue Growth with ₹300 Crore Capex Plan Amid Strong Q2 Performance
1 day ago
Innova Captab Limited has announced a growth strategy targeting a 25% revenue increase through CDMO business expansion and entry into regulated markets. The company plans to invest ₹300 crore in capital expenditure for capacity addition and R&D. Q2 FY26 financial results show 19.50% YoY revenue growth to ₹380.40 crore, 8% EBITDA growth to ₹56.10 crore, and PAT of ₹29.70 crore. The company's strategy includes strengthening API production, scaling up formulation exports, expanding oncology portfolio, and enhancing margins through vertical integration and global partnerships. Recent regulatory inspections of facilities in Baddi and Jammu reinforce the company's adherence to global quality standards.
Innova Captab's Jammu Facility Poised for GMP Compliance Certificate from Ukraine Drug Authority
Oct 20, 2025
Innova Captab Faces ₹15.81 Crore GST Demand Over Excess Input Tax Credit Refund Claims
Oct 16, 2025
Innova Captab Reports Robust Q1 Results with 19% Revenue Growth
Aug 07, 2025
Innova Captab Reports Strong Q4 Performance with Improved EBITDA and Revenue Growth
May 19, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation